3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Unknown
3
Recruiting
2
Not yet recruiting
2
Withdrawn
1
Completed
1
Sponsor Class
OTHER
6
OTHER_GOV
2
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Uveal Melanoma
2
Melanoma
2
Interventions
tislelizumab
12
Capecitabine
8
Carboplatin
5
Surgical Procedures, Operative
4
Oxaliplatin
4
Drug Therapy
4
apatinib
3
Paclitaxel
3
Cisplatin
3
Bevacizumab
3
ivarmacitinib
2
anlotinib
2
Standard of Care
2
Radiotherapy
2
Radiation
2
Methods
2
Melphalan
2
Low-Level Light Therapy
2
Letrozole
2
Interleukin-2
2
Injections
2
Immunotherapy
2
Cryotherapy
2
zanubrutinib
1
trastuzumab deruxtecan
1
toripalimab
1
surufatinib
1
sintilimab
1
pyrotinib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER_GOV
×
Interleukin-2
×
Clear all
NCT07183852
2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1
Not yet recruiting
18 enrolled
NCT05903937
2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1
Not yet recruiting
6 enrolled